Pharma Market Access Insights - from Mtech Access
Całkowity czas trwania:
38 h 11 min
Rare Disease market access in the MENA and Nordic regions
Pharma Market Access Insights - from Mtech Access
59:10
How does funding flow in NHSE Regions?
Pharma Market Access Insights - from Mtech Access
60:15
NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)
Pharma Market Access Insights - from Mtech Access
62:06
De-mystifying health economic model classifications and structures
Pharma Market Access Insights - from Mtech Access
60:28
Evidence strategy for Medical Technologies and Diagnostics
Pharma Market Access Insights - from Mtech Access
53:24
How to set your Pharma or Medtech product up for success in the US market
Pharma Market Access Insights - from Mtech Access
43:06
What's happening with specialised commissioning in the NHS?
Pharma Market Access Insights - from Mtech Access
60:08
Integrated care in NHS Wales – what can England learn from its neighbour?
Pharma Market Access Insights - from Mtech Access
56:24
Market access in Italy: Reforms at AIFA
Pharma Market Access Insights - from Mtech Access
43:36
Unmet need in NHS primary care – How can industry best support PCN leaders?
Pharma Market Access Insights - from Mtech Access
60:44
Population health management: a community effort across health and life sciences
Pharma Market Access Insights - from Mtech Access
64:01
Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access
Pharma Market Access Insights - from Mtech Access
39:54
6 areas of UK health policy for Medtech to pay attention to
Pharma Market Access Insights - from Mtech Access
61:49
Market access in the German speaking markets
Pharma Market Access Insights - from Mtech Access
57:59
The role of nursing in driving digital change in the NHS
Pharma Market Access Insights - from Mtech Access
54:50
Market access for digital therapies and digital medicines
Pharma Market Access Insights - from Mtech Access
42:18
A global market access journey in cannabinoid pharmaceuticals
Pharma Market Access Insights - from Mtech Access
53:47
Primary Care and ICBs – what is the next step in the integration journey?
Pharma Market Access Insights - from Mtech Access
61:17
Data-led transformation in the NHS - partnering to optimise patient care
Pharma Market Access Insights - from Mtech Access
62:35
Innovating for better health – research, collaboration and innovation in the NHS
Pharma Market Access Insights - from Mtech Access
57:56
Healthcare, economics and society – unlocking NHS collaboration
Pharma Market Access Insights - from Mtech Access
59:23
Specialised Commissioning in the NHS – What do you need to know now
Pharma Market Access Insights - from Mtech Access
60:34
Why are we waiting? - Pressures facing the NHS and how to deliver change
Pharma Market Access Insights - from Mtech Access
60:47
Priority setting in primary care - NHS insights
Pharma Market Access Insights - from Mtech Access
59:35
Integrated Care Systems go live in the NHS - reflections after 3 weeks
Pharma Market Access Insights - from Mtech Access
60:21
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role
Pharma Market Access Insights - from Mtech Access
60:46
Transforming systems and care pathways for an integrated NHS
Pharma Market Access Insights - from Mtech Access
60:47
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers
Pharma Market Access Insights - from Mtech Access
39:25
Population to Person: How will the NHS translate population health management into impactful, person-centred service change?
Pharma Market Access Insights - from Mtech Access
56:04
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?
Pharma Market Access Insights - from Mtech Access
59:25
The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion
Pharma Market Access Insights - from Mtech Access
62:57
Optimising the NHS – How will medicines be valued in integrated systems?
Pharma Market Access Insights - from Mtech Access
54:03
Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe
Pharma Market Access Insights - from Mtech Access
60:49
A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales)
Pharma Market Access Insights - from Mtech Access
59:33
Innovations to address health inequalities in the NHS and how Pharma and Medtech can help
Pharma Market Access Insights - from Mtech Access
59:29
The hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems moving
Pharma Market Access Insights - from Mtech Access
59:55
Population to person - How will the voice of the individual drive health and care development?
Pharma Market Access Insights - from Mtech Access
61:57
Know your Place - where will power really sit in the new NHS - with Dr Steven Michael OBE
Pharma Market Access Insights - from Mtech Access
61:12
Health Economic Modelling for MedTech Innovation - What, Why and How
Pharma Market Access Insights - from Mtech Access
60:34
Pharmacy, Medicines, and Specialised Commissioning in the new NHS
Pharma Market Access Insights - from Mtech Access
58:29